**Question:** Withdraw! bleeding occurs when progestins administered continuously:

A. Oral contraceptives
B. Hormone Replacement Therapy (HRT)
C. Transdermal Contraceptive Patch
D. Menopausal Hormone Therapy (MHT)

**Core Concept:**

Progestins are synthetic progesterone derivatives used in various hormonal therapies, including oral contraceptives, hormone replacement therapy (HRT), transdermal contraceptive patches, and menopausal hormone therapy (MHT). Progestins exert their actions primarily through binding to progesterone receptors, altering gene expression, and promoting endometrial changes.

**Why the Correct Answer is Right:**

Continuous administration of progestins results in a state of endometrial hyperplasia (excessive endometrial growth) due to the prolonged exposure to progestin. This can lead to an imbalance between endometrial cell proliferation and apoptosis (cell death), causing the endometrium to become thin and irregular. Continuous progestin administration also disrupts the normal cyclical changes in the endometrium, leading to withdrawal bleeding when progestin administration is stopped.

**Why Each Wrong Option is Incorrect:**

A. Oral contraceptives (OCP): Progestins are an essential component of combined oral contraceptives (COC), along with estrogens. Continuous administration of COC causes endometrial changes but does not explain withdrawal bleeding upon discontinuation.

B. Hormone Replacement Therapy (HRT): HRT primarily focuses on addressing menopausal symptoms and does not always involve continuous progestin administration. Unlike continuous progestin administration, HRT usually involves cyclic hormone administration.

C. Transdermal Contraceptive Patch: Similar to oral contraceptives, transdermal contraceptives involve cyclic hormone administration, preventing endometrial changes similar to continuous progestin administration.

D. Menopausal Hormone Therapy (MHT): MHT, like HRT, does not solely involve continuous progestin administration, as it often combines estrogens and progestins in cyclic regimens.

**Clinical Pearl:**

In clinical practice, understanding the mechanism of withdrawal bleeding upon discontinuation of continuous progestin administration is crucial for appropriate counseling of patients and managing their expectations regarding menstrual cycle changes during hormonal therapy. Inform patients that withdrawal bleeding is a normal consequence of discontinuing continuous progestin administration, and it usually resolves within a few months as the endometrium reverts to its pre-treatment state.